Current Edition

Accelerating the Pace of Study Start-up
Editorial Archive

Accelerating the Pace of Study Start-up

Launching a new clinical study is an exciting stage of product development. There is tremendous hope that a new drug will cure illness or bring relief to patients. In...
Continue Reading →
Safety in the Spotlight: A Risk-based Approach to Biosimilars
Editorial Archive

Safety in the Spotlight: A Risk-based Approach to Biosimilars

Biosimilars have important cost benefits to offer the overall healthcare system, and they give access to treatment for patients with rare or very serious illnesses th...
Continue Reading →